Improving Sleep, Sleep-related Outcomes, and Biomarkers in Veterans
1 other identifier
interventional
300
1 country
1
Brief Summary
The primary purpose of this project is to determine the effect of morning bright light therapy (MBLT) on sleep in Veterans with traumatic brain injury (TBI). Secondarily, the project aims to identify blood-based brain biomarkers (BBBM) associated with sleep in Veterans. Specific Aim 1. Determine the effect of MBLT on sleep quality in Veterans (primary outcome). Specific Aim 2. Determine the effect of MBLT on downstream effectors of improved sleep, including cognition, mood, and quality of life measures in Veterans (exploratory outcomes). Specific Aim 3. Determine the effect of MBLT on levels of specific BBBM related to sleep, and whether changes in specific BBBM predict response to MBLT (secondary outcome). This study can now be completed 100% remotely.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Aug 2019
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 23, 2019
CompletedFirst Posted
Study publicly available on registry
May 30, 2019
CompletedStudy Start
First participant enrolled
August 1, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2025
CompletedNovember 14, 2025
November 1, 2025
6.3 years
May 23, 2019
November 12, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in Insomnia Severity Index (ISI)
Measures self-reported insomnia severity; total score range = 0-28 (higher total score = worse insomnia)
Baseline; after 4 weeks of intervention; and 2 months after the end of intervention
Secondary Outcomes (1)
Change in NFL, GFAP, UCH-L1, and total tau
Baseline; after 4 weeks of intervention; and 2 months after the end of intervention
Study Arms (2)
Light box
EXPERIMENTALCommercially available lightbox emitting 10,000 lux of light. Subjects asked to use lightbox everyday for an hour for 4 weeks upon waking.
Negative Ion Generator
SHAM COMPARATORCommercially available negative ion generator. Subjects asked to use everyday for an hour for 4 weeks upon waking.
Interventions
The intervention is sitting in front of a lightbox for 1 hour in the morning upon waking up.
The intervention is sitting in front of a modified negative ion generator for 1 hour in the morning upon waking up.
Eligibility Criteria
You may qualify if:
- Veteran
- English-speaking
- Accessible by phone
You may not qualify if:
- Decisional impairment
- Macular degeneration
- Bipolar disorder
- Shift work
- Currently using lightbox or negative ion generator
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Portland VA Medical Center
Portland, Oregon, 97239, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Miranda Lim, MD, PhD
Portland VA
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- FED
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
May 23, 2019
First Posted
May 30, 2019
Study Start
August 1, 2019
Primary Completion
December 1, 2025
Study Completion
December 1, 2025
Last Updated
November 14, 2025
Record last verified: 2025-11
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ICF, CSR, ANALYTIC CODE
- Time Frame
- Information will be sent as soon as is practical and will be available as long as the PI is available.
- Access Criteria
- Legitimate research agenda, including but not limited to request to double-check presented or published results and novel analyses.
All non-identifiable data will be made available to qualified researchers on request to the study PI.